Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders. - Archive ouverte HAL Access content directly
Journal Articles British Journal of Haematology Year : 2010

Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders.

(1, 2) , (3) , (2) , (4) , (2) , (2) , (5) , (2)
1
2
3
4
5

Abstract

Lowe syndrome (LS) is a rare X-linked disorder caused by mutations in the oculocerebrorenal gene (OCRL), encoding OCRL, a phosphatidylinositol 5-phosphatase with a RhoGAP domain. An abnormal rate of haemorrhagic events was found in a retrospective clinical survey. Herein, we report the results of exploration of haemostasis in six LS patients. All patients had normal coagulation tests but prolonged closure times (CTs) in the PFA-100 system. Healthy donors' blood samples incubated with a RhoA kinase inhibitor had prolonged CTs. This suggests that an aberrant RhoA pathway in platelets contributes to CT prolongation and primary haemostasis disorders in LS.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-00588304 , version 1 (13-07-2011)

Identifiers

Cite

Dominique Lasne, Geneviève Baujat, Tristan Mirault, Joël Lunardi, Françoise Grelac, et al.. Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders.. British Journal of Haematology, 2010, 150 (6), pp.685-8. ⟨10.1111/j.1365-2141.2010.08304.x⟩. ⟨inserm-00588304⟩
162 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More